Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1401 - 1408 of 11617 results
What’s New in 5G - March 2023
March 1, 2023| Blog| Viewpoint
New York Proposes Regulatory Review and Approval of Material Health Care Entity Transactions
March 1, 2023| Blog| Viewpoint
An Overview of Why Class Action Privacy Lawsuits May Have Just Gotten Bigger – Yet Again.
March 1, 2023| Blog| Viewpoint
Post-Roe, Prosecutors Can Seek Unprotected Reproductive Health Data
March 1, 2023| News
EPA Poised To Offer Early WOTUS Defense In Response To Injunction Push
March 1, 2023| News
Telephone and Texting Compliance News — February 2023
February 28, 2023| Article| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.